Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

A researcher at Albert Einstein College of Medicine of Yeshiva University has helped to develop the first genetic blood test for predicting the chances that in vitro fertilization will lead to a successful pregnancy.

13 Jan 2011

Study indicates disease's underlying causes in mice, finds compounds that normalize Alzheimer's brain

A Blanchette Rockefeller Neurosciences Institute study published today in the Journal of Neuroscience reveals underlying causes for the degeneration of synapses in Alzheimer's Disease and identifies promising pharmaceutical solutions for the devastating condition that affects more than 5 million people in the United States.

12 Jan 2011

Educational psychologist calls for national review of medicating children to treat behavioural issues

According to the NHS Business Service Authority, some prescriptions of amphetamines for children have increased nearly 120 fold between 1994 and 2009. This is causing ongoing concern amongst some educational and child psychologists.

12 Jan 2011

Lightning Process training course tops in survey by ME/ CFS

A revolutionary self training course has emerged top in a survey conducted by the Sussex and Kent ME/ CFS Society.

12 Jan 2011

Lipoprotein receptor LRP1 also regulates food intake and energy balance in central nervous system: Study

A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.

12 Jan 2011

Dream team to build mind-controlled prosthetic devices

University of Houston researchers are helping the Pentagon build reliable mind-controlled prosthetic devices that military and civilian amputees can use the rest of their lives.

12 Jan 2011

Study reveals underlying causes for degeneration of synapses in Alzheimer's Disease

A Blanchette Rockefeller Neurosciences Institute (BRNI) study published today in the Journal of Neuroscience reveals underlying causes for the degeneration of synapses in Alzheimer's Disease and identifies promising pharmaceutical solutions for the devastating condition that affects more than 5 million people in the United States.

12 Jan 2011

U.N. has 'largely' met its goals in Haiti since the quake, official says

The U.N. has mostly achieved its short-term goals since a major earthquake struck Haiti on January 12, 2010, Nigel Fisher, the U.N. humanitarian coordinator for Haiti, said during a video teleconference on Monday, Deutsche Presse-Agentur/M&C reports.

12 Jan 2011

Neurology professor receives MFRF's 'See the Light' award for Tay-Sachs research

Miguel Sena-Esteves, PhD, associate professor of neurology at the University of Massachusetts Medical School, was presented with the annual "See the Light" award from the Mathew Forbes Romer Foundation in recognition of his work for leading the fight against children's genetic diseases of the brain.

12 Jan 2011

NIDA awards Scripps Research, University of Pennsylvania $8.2M grant to develop tobacco addiction treatment

The Scripps Research Institute and the University of Pennsylvania School of Medicine have been awarded approximately $8.2 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of tobacco addiction. Of the funds awarded, $5.7 million will go to Scripps Research, and $2.5 million to the University of Pennsylvania.

12 Jan 2011

Hybrid cochlear implant may benefit patients with profound hearing loss

Northwestern Memorial Hospital is one of nine centers in the U.S., and the only in Illinois, that is participating in a study investigating the effectiveness of a new cochlear implant device that aims to restore hearing for individuals with high-frequency hearing loss and functional low-frequency hearing.

12 Jan 2011

CAMH scientists receive NARSAD's Young Investigator grant awards for brain and behavior research

Seven scientists at Canada's Centre for Addiction and Mental Health have been awarded Young Investigator grant awards by the U.S.-based NARSAD: The Brain and Behavior Research Fund.

12 Jan 2011

5 easy steps to improve heart health

Did you know that a good night's sleep can help prevent heart disease? There are many simple ways to lower your risk.

12 Jan 2011

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Transplanting their own bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report researchers publishing in the current issue of Cell Transplantation. Yet, the mechanism by which the infusion of CD34+ stem cells improves liver function remains elusive, they say.

11 Jan 2011

Eric Lancaster receives NORD grant to study stiff-person syndrome

The National Organization for Rare Disorders has awarded a research grant for the study of stiff-person syndrome, a rare acquired neurological disorder, to Eric Lancaster, MD, PhD of the University of Pennsylvania.

11 Jan 2011

Nicotine may act as treatment for some symptoms of schizophrenia

Smoking is a common problem for patients with schizophrenia. The increased tendency of patients diagnosed with this disorder is to not only smoke, but to do so more heavily than the general public. This raises the possibility that nicotine may be acting as a treatment for some symptoms of schizophrenia.

11 Jan 2011

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.

11 Jan 2011

Brain News and Research

Further Reading

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

Study indicates disease's underlying causes in mice, finds compounds that normalize Alzheimer's brain

Educational psychologist calls for national review of medicating children to treat behavioural issues

Lightning Process training course tops in survey by ME/ CFS

Lipoprotein receptor LRP1 also regulates food intake and energy balance in central nervous system: Study

Dream team to build mind-controlled prosthetic devices

Study reveals underlying causes for degeneration of synapses in Alzheimer's Disease

U.N. has 'largely' met its goals in Haiti since the quake, official says

Neurology professor receives MFRF's 'See the Light' award for Tay-Sachs research

NIDA awards Scripps Research, University of Pennsylvania $8.2M grant to develop tobacco addiction treatment

Hybrid cochlear implant may benefit patients with profound hearing loss

CAMH scientists receive NARSAD's Young Investigator grant awards for brain and behavior research

5 easy steps to improve heart health

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Eric Lancaster receives NORD grant to study stiff-person syndrome

Nicotine may act as treatment for some symptoms of schizophrenia

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

Cleveland Clinic and MedStar Health collaborate to create Innovation Alliance

Mithridion secures commitments of $1.25 million in new funding

Positive results from Allovectin-7 Phase 3 trial in patients with metastatic melanoma

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News